Table 1:
Study population
| Median / n | Range | |
|---|---|---|
| Age (years) | 42 | 15–63 |
| Male | 6 | |
| Veno-arterial ECMO (n = 4) | ||
| Age (years) | 58 | 55–63 |
| Male (n) | 2 | |
| Blood lactate (mmol/l) | 8.7 | 4–12 |
| Troponin | 10 | 8–12 |
| Bilirubin (μmol/l) | 26.5 | 20–33 |
| ASAT (UI/L) | 972 | 432–2230 |
| ALAT (UI/L) | 621 | 203–1867 |
| Prothrombin activity (%) | 53 | 41–65 |
| Creatinine (μmol/l) | 125 | 61–193 |
| Dobutamine (μg/kg/min) | 22.5 | 0–30 |
| Epinephrine (μg/kg/min) | 0.7 | 0–1.2 |
| Norepinephrine (μg/kg/min) | 0.5 | 0–0.75 |
| Veno-venous ECMO (n = 8) | ||
| Age (years) | 22 | 15–43 |
| Male (n) | 4 | |
| pH | 7.2 | 7.12–7.35 |
| PaO2 (mmHg) | 63.8 | 45–84 |
| PaCO2 (mmHg) | 68.7 | 57–85 |
| PaO2/FiO2 | 65 | 50–84 |
| TV (ml/kg) | 4.875 | 4.61–5.14 |
| PEEP (cmH2O) | 16 | 12–20 |
| NO (ppm) | 12 | 0–15 |